The Marle Group, which manufactured a million implants last year for an annual turnover of 85 M€, announced the acquisition of Finortho SAS on 30 October 2015.
Leader in industrial manufacturing of orthopedic implants, Marle offers one of the most comprehensive panels of production technology in the world. This year the company enhanced its internal capabilities by launching a high performance anodizing line perfectly adapted to generating color on titanium implants.
A worldwide leader in the production of hip stems, Marle also has extensive experience in industrializing instruments for orthopedic surgery. The Marle teams regularly develop proprietary manufacturing techniques, which improve ergonomics and operating effectiveness of instruments and insertion ancillaries.
With a massive investment of over one million euros, in early 2014, Marle established a workflow in clean rooms, which covers both the coating and packaging of orthopedic implants: the guarantee of maximum safety.
In early 2014, Marle integrated a plasma torch, which allows for the production of hydroxyapatite (HAP), a ceramic-based coating powder in a monolayer application. This investment will complement the technologies mastered internally by the leader of the industrial manufacturing of orthopedic implants in Europe.
3D printing technologies are used for a wide variety of applications such as customized implants, test parts, very small series, Marle equipment is at your disposal to give an efficient response to your projects.
Following its successful participation in june 2013, Marle will exhibit at Omtec 2014.